We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+16.92%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$856M
AUM Growth
-$46.4M
Cap. Flow
-$173M
Cap. Flow %
-20.16%
Top 10 Hldgs %
41.76%
Holding
72
New
17
Increased
18
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$40.9M
2
NVS icon
Novartis
NVS
+$35.1M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$25.7M
4
VTRS icon
Viatris
VTRS
+$24.6M
5
EW icon
Edwards Lifesciences
EW
+$18.8M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$53.6M
2
CI icon
Cigna
CI
+$28.3M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$26M
4
AET
Aetna Inc
AET
+$22.6M
5
BIIB icon
Biogen
BIIB
+$20.7M

Sector Composition

Rank Sector Weight
1 Healthcare 94.17%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
51
Illumina
ILMN
$28.7B
$1.94M 0.23%
+11,668
New +$1.84M
INSM icon
52
Insmed
INSM
$22.7B
$1.94M 0.23%
110,599
+7,299
+7% +$113K
TGTX icon
53
TG Therapeutics
TGTX
$8.53B
$1.6M 0.19%
+137,500
New +$987K
CRVS icon
54
Corvus Pharmaceuticals
CRVS
$1.09B
$1.4M 0.16%
+67,200
New +$1.05M
RDY icon
55
Dr. Reddy's Laboratories
RDY
$9.8B
$1.29M 0.15%
160,775
– –
ALNY icon
56
Alnylam Pharmaceuticals
ALNY
$37.2B
$1.28M 0.15%
24,899
+5,000
+25% +$231K
AVXS
57
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.14M 0.13%
14,950
-8,265
-36% -$512K
CLDX icon
58
Celldex Therapeutics
CLDX
$2.8B
$914K 0.11%
+16,879
New +$879K
SAGE
59
DELISTED
Sage Therapeutics
SAGE
$867K 0.1%
12,199
-15,700
-56% -$920K
SRPT icon
60
Sarepta Therapeutics
SRPT
$1.68B
$852K 0.1%
28,799
– –
TRIL
61
DELISTED
Trillium Therapeutics Inc.
TRIL
$789K 0.09%
128,272
+28,272
+28% +$166K
OBSV
62
DELISTED
ObsEva SA Ordinary Shares
OBSV
$786K 0.09%
+75,500
New +$927K
ALBO
63
DELISTED
Albireo Pharma Inc
ALBO
$485K 0.06%
+20,224
New +$440K
SRRA
64
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$309K 0.04%
+5,042
New +$293K
CI icon
65
Cigna
CI
$77B
– –
-212,424
Closed -$28.3M
LLY icon
66
Eli Lilly
LLY
$1.07T
– –
-729,117
Closed -$53.6M
ICPT
67
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-74,150
Closed -$8.06M
AET
68
DELISTED
Aetna Inc
AET
– –
-182,185
Closed -$22.6M
ENTL
69
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
– –
-130,496
Closed -$2.48M
SCAI
70
DELISTED
Surgical Care Affiliates, Inc.
SCAI
– –
-98,300
Closed -$4.55M
1 2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, Sectoral Asset Management held 72 positions worth $856M, down 5.1% from $903M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sectoral Asset Management withdrew a net $173M in Q1 2017, closing 7 positions and reducing 27 holdings. Its most notable exit was Eli Lilly, an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 90% a quarter earlier, followed by Financials.

Against the trend, Sectoral Asset Management opened a new position in Johnson & Johnson worth $42.6M.

  • Sectoral Asset Management's largest Q1 2017 buy was Johnson & Johnson: 342,350 shares worth $42.6M.
  • Sectoral Asset Management added most to K2M Group Holdings, Inc in Q1 2017, an estimated $14M increase.
  • Sectoral Asset Management's biggest Q1 2017 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $26M.
  • Sectoral Asset Management fully exited Eli Lilly in Q1 2017, selling an estimated $53.6M.
  • Sectoral Asset Management's ten largest holdings make up 42% of its $856M portfolio in Q1 2017.
  • Sectoral Asset Management opened 17 new positions and closed 7 in Q1 2017.
  • Sectoral Asset Management's portfolio value fell 5.1% quarter-over-quarter to $856M.

Based on Sectoral Asset Management's 13F filing for Q1 2017, filed 15 May 2017.